BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
10/19/18 Clovis Oncology (CLVS) Rubraca for Prostate Cancer Subscribers Only Subscribers Only Subscribers Only
10/19/18 Bristol-Myers Squibb (BMY) Opdivo for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
10/18/18 UCB (UCB:BB) Rozanolixizumab for Myasthenia Gravis (MG) Subscribers Only Subscribers Only Subscribers Only
10/18/18 Merck (MRK) Keytruda for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only
10/18/18 Shire (SHPG) SHP555 for Chronic Idiopathic Constipation Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
10/20/18 Subscribers Only Subscribers Only Trial Data - Top-Line Results
10/20/18 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
10/20/18 Subscribers Only Subscribers Only Trial Data - Top-Line Results
10/20/18 Subscribers Only Subscribers Only Trial Data - Top-Line Results
10/20/18 Subscribers Only Subscribers Only Trial Data - Updated Results
Back to the top Back to the top